Global Consortium - The State of California Issues Manufacturing License for Adult and Medical Cannabis Products

• Indulge Oils to resume operations
• Global Consortium Group, LLC to be acquired early next year
• Infused Edibles will resume sales of THC Infused Edibles

COCONUT CREEK, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Global Consortium, Inc. (OTCPINK: BDCI) is pleased to announce the State of California has issued a temporary manufacturing license allowing operations in the facility to begin.

The temporary manufacturing license for adult and medical cannabis products issued to Global Consortium Group, LLC, means Indulge Oils and Infused Edibles can begin selling THC products generating revenue for the company from cannabis sales.

Infused Edibles began lining up orders for THC infused edibles, and ordered 50,000 of the new packaging as required July 1, 2018. Indulge Oils has clients ready to accept pens and cartridges.

The temporary manufacturing license allows two more SIGNIFICANT revenue streams to come online for Global. As stated in our financials, Indulge Oils at full capacity will generate $1,000,000 per month net. The larger extractor will be ordered this month now that the license has been granted. The new, larger extractor should come online in about 8 weeks.

Global Consortium Group, LLC is the California company Global mentioned in a previous release it plans on acquiring.

The company continues to work with FINRA to complete the Name and Ticker change filed in October after the closing of the merger. Based on the latest information, the company feels the changes are close to taking effect.

Bahamas Development Corporation, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg FD.

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.

Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.

For additional information about this release please contact:

Investor Relations:

Matt Dwyer
matt@cannabisconsortium.net
www.cannabisconsortium.net
954-906-0098